Soren Cold

Sdr. Boulevard 29
Odense C, 5000, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial.

Adjuvant Docetaxel and Cyclophosphamide With or Without Epirubicin for Early Breast Cancer: Final Analysis of the Randomized DBCG 07-READ Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 23, 2024

Response to Van Cauwenberge, Borremans, Van Houdt, et al.

Response to Van Cauwenberge, Borremans, Van Houdt, et al.

Journal: Journal of the National Cancer Institute

Published: March 31, 2023

Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases.

Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases.

Journal: Cancer medicine

Published: March 02, 2023

Response to Pederson et al. and Chlebowski et al.

Response to Pederson et al. and Chlebowski et al.

Journal: Journal of the National Cancer Institute

Published: October 24, 2022

Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial.

Long-Term Selenium-Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo-Controlled Trial.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: May 03, 2022

Communication Skills Training: A Means to Promote Time-Efficient Patient-Centered Communication in Clinical Practice.

Communication Skills Training: A Means to Promote Time-Efficient Patient-Centered Communication in Clinical Practice.

Journal: Journal of patient-centered research and reviews

Published: November 01, 2021

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.

Journal: Journal of the National Cancer Institute

Published: October 18, 2021

Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients.

Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients.

Journal: Echocardiography (Mount Kisco, N.Y.)

Published: June 03, 2021

Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).

Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 10, 2021

Comparison of the Metastasis Predictive Potential of mRNA and Long Non-Coding RNA Profiling in Systemically Untreated Breast Cancer.

Comparison of the Metastasis Predictive Potential of mRNA and Long Non-Coding RNA Profiling in Systemically Untreated Breast Cancer.

Journal: Cancers

Published: May 08, 2021

Neoadjuvant chemotherapy for primary operable breast cancer.

Neoadjuvant chemotherapy for primary operable breast cancer.

Journal: Danish medical journal

Published: December 03, 2020

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Journal: Clinical breast cancer

Published: September 10, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026